Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Healthcare Industry News NuSirt Health launches LEUSIX supplement for weight management and metabolic health NuSirt Health has unveiled its latest innovation, LEUSIX, a dietary supplement designed to aid weight management and improve… byPallavi MadhirajuNovember 28, 2024